Form 4: Longeveron CTO Devin Blass Awarded Significant Equity Compensation

Longeveron Inc.'s CTO and SVP of CMC, Devin Blass, was granted 102,000 Restricted Stock Units and options to purchase 34,000 shares of Class A Common Stock.

Summary

• Devin Blass, the Chief Technology Officer (CTO) and Senior Vice President (SVP) of Chemistry, Manufacturing, and Controls (CMC) at Longeveron Inc. (LGVN), reported an acquisition of equity securities.
• On July 15, 2025, Blass was awarded 102,000 shares of Class A Common Stock in the form of time-based vesting Restricted Stock Units (RSUs) at a price of $0.
• Following this transaction, the total amount of Class A Common Stock beneficially owned by Blass is 218,485 shares, which includes RSUs subject to future vesting.
• Additionally, Blass was granted stock options to purchase 34,000 shares of Class A Common Stock with an exercise price of $1.47 per share.
• These stock options will vest quarterly over a three-year period, commencing on October 1, 2025, and have an expiration date of July 15, 2035.

Sentiment

Score: 7

Explanation: The filing reports a standard grant of equity compensation to a key executive, which is generally viewed positively as it aligns management incentives with shareholder interests and aids in executive retention.

Positives

• The grant of equity compensation, including Restricted Stock Units and stock options, aligns the executive's financial interests with those of the shareholders, promoting long-term value creation.
• A significant equity award to a key executive like the CTO and SVP of CMC indicates a commitment to retaining critical talent and incentivizing performance within the company.

Future Outlook

The stock options granted to Devin Blass are set to vest quarterly over a three-year period, beginning on October 1, 2025, indicating a long-term incentive structure for the executive.

Industry Context

The grant of equity compensation to a key executive is a standard practice across various industries, particularly in biotechnology and life sciences, to attract, retain, and incentivize top talent by aligning their long-term interests with the company's performance and shareholder value.

Stakeholder Impact

• Shareholders: The equity grant aligns the interests of a key executive with shareholders, potentially leading to improved long-term performance and value creation.
• Management: The executive receives a significant long-term incentive through RSUs and stock options, enhancing their stake in the company's success.

Next Steps

• The stock options will begin vesting quarterly over a three-year period starting October 1, 2025.

Key Dates

Keywords

Longeveron Inc., LGVN, Devin Blass, SEC Form 4, equity compensation, Restricted Stock Units, RSUs, stock options, executive compensation, insider transaction, beneficial ownership